ArticleCancer communications (London, England)2021

CRISPR/Cas9 screening identifies a kinetochore-microtubule dependent mechanism for Aurora-A inhibitor resistance in breast cancer.

Ailin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.